Skip to content

Author

Katelyn L. O'Neill

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#protein folding Open access Oct 2026

Chemical genetic screens combine target dependence with efficacy: discovery of a MAP3K1 degrader (HBC-8) with anticancer activities

Heterobifunctional compounds (HBCs) that facilitate target protein degradation (TPD) by recruiting an E3 ligase complex have emerged as therapeutic options for cancer. Current screening approaches often prioritize protein degradation over anticancer activity, potentially missing therapeutically relevant compounds. To a...

Lelisse T. Umeta, J. Mallareddy, Sarbjit Singh et al. · 0 citations
Open access Jul 2026

Integrative Proteomic Analysis Implicates Inhibition of Intracellular Protein Trafficking in Therapy-Induced Migrastasis in Prostate Cancer

KU2046-induced migrastasis appears to operate through spatial decoupling rather than structural degradation, providing a correlative framework to inhibit metastatic dissemination independent of direct cytotoxicity.

Weining Chen, Saadyeh Rashidi, H. Law et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.